- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Politics vs Science: The Future of US Public Health
On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
On this newest episode of Managed Care Cast, we are speaking with Perry N. Halkitis, PhD, MS, MPH, dean, Hunterdon Professor of Public Health & Health Equity, and distinguished professor at the Rutgers School of Public Health. Using his expertise in infectious disease epidemiology, public health psychology, and health behavior, our conversation centers on the potential withdrawal of the United States from the World Health Organization (WHO), the new directive for the CDC to stop communications with the WHO, and their public health implications. We also touch on the importance of accurate public health information and the role of public health leaders in advocating for science and health.
Listen above or through one of these podcast services:
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
